You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

BIO Welcomes Gene Harrington as Director of Food and Agriculture for BIO State Government Relations

Mar 16 2015
BIO today announced that agriculture industry expert Gene Harrington has joined the organization as Director of State Advocacy and State Government Affairs for Food and Agriculture within the Alliance Development & State Government Relations Department.

BIO Urges Governor Hickenlooper to Sign Bill That Ensures Patient Access to Interchangeable Biologic Medicines

Mar 12 2015
The Biotechnology Industry Organization (BIO) and the Colorado BioScience Association (CBSA) call upon Governor Hickenlooper to sign critical legislation to create a pathway for the substitution of interchangeable biologic medicines.

Veteran Journalist Tom Brokaw to Deliver Keynote Address at the 2015 BIO International Convention

Mar 12 2015
Washington, D.C. (March 12, 2015) – Legendary television journalist and author Tom Brokaw will deliver a keynote address at the 2015 BIO International Convention®, June 15-18 in Philadelphia, Pennsylvania. The Keynote Luncheon will take place on Tuesday, June 16 from 12:00 – 1:30 pm EDT. The BIO International Convention regularly draws over 15,000 leaders from the biopharmaceutical industry, and offers targeted networking and business partnering opportunities and provides insights and inspiration on major trends affecting the industry.

BIO Condemns Destruction of Research at Brazil GE Tree Facility

Mar 9 2015
Washington, D.C. (March 9, 2015) – Late last week, approximately one thousand individuals representing MST (Brazil’s Landless Workers Movement) invaded the operations of genetically engineered (GE) tree company Futuragene in Brazil.    

BIO Statement on First FDA Approval of a Biosimilar Product

Mar 6 2015
Washington, D.C. (March 6, 2015) – The Biotechnology Industry Organization (BIO) issued the following statement today regarding the approval by the Food and Drug Administration (FDA) of the first biosimilar product under the pathway created by the Biologics Price Competition and Innovation Act (BPCIA).

BIO Statement of Support for the Introduction of the STRONG Patents Act of 2015

Mar 3 2015
BIO supports the STRONG Patents Act of 2015 and will continue to advocate for passage of legislation to curb abusive patent practices.

BIO Extends its Nomination Deadline for the Second Annual Rosalind Franklin Award

Feb 27 2015
The Biotechnology Industry Organization (BIO) has officially extended its deadline for the Rosalind Franklin Award for Leadership in Industrial Biotechnology.  In its second year, the BIO Rosalind Franklin Award was created to honor an outstanding woman in the field of industrial biotechnology and bioprocessing.  The Rosalind Franklin Society will sponsor the 2015 BIO Rosalind Franklin Award which will be presented at the 2015 World Congress on Industrial Biotechnology to be held July 19-22, 2015 at the Palais des congrès de Montréal in Montréal, Canada.  

BIO Applauds COMPETE Act to Encourage Critical Early-Stage Biotech Research

Feb 25 2015

...

BIO Applauds COMPETE Act to Encourage Critical Early-Stage Biotech Research

Feb 25 2015

...

BIO Strongly Supports FDA Safety over Sequestration Act; Urges Swift Consideration and Passage

Feb 25 2015
Washington, D.C. (February 25, 2015) – The Biotechnology Industry Organization (BIO) today applauds Representatives Leonard Lance (R-NJ) and Anna Eshoo (D-CA) for introducing the FDA Safety Over Sequestration Act, or FDA SOS Act. The Act would exempt privately-paid user fees paid to the FDA from any future operation of sequestration.